Document is current
Any future updates will be listed below
-
Authors
Anukoolwittaya, Prakit
Rattanawong, Wanakorn
Vongvaivanich, Kiratikorn
Pongpitakmetha, Thanakit
Thanprasertsuk, Sekh
Poonpedpun, Thaninjitra
Soontrapa, Pannathat
Suwanlaong, Kanokrat
Kongbunkiat, Kannikar
Komonchan, Surasak
Dusitanond, Petcharat
Teekaput, Chutithep
Sirimaharaj, Nopdanai
Yuvasilp, Nadolporn
Tanprawate, Surat
-
Funding
Funding for this research was provided by:
Pfizer (Thailand) Ltd.
- License Information
-
More Information
Article History
Received: 23 April 2025
Accepted: 22 May 2025
First Online: 2 June 2025
Declarations
:
: Not applicable.
: Not applicable.
: PA has received speaker and advisory board honoraria from BL HUA, DKSH, Lundbeck, Pfizer, and ZP therapeutics. WR declares receiving speaker and advisory board honoraria from BL HUA, DKSH, Lundbeck, Pfizer, Viatris and ZP therapeutics. KV discloses participation in speaker’s bureaus for Abbott, AbbVie, Daiichi Sankyo, DKSH, Eli Lilly, GSK, Lundbeck, Merck, Novartis, Pfizer, Servier, Teva Pharma, Viatris, ZP therapeutics and Zuellig Pharma, as well as being a consultant for Daiichi Sankyo, Lundbeck, Novartis, Pfizer, Teva Pharma, and Zuellig Pharma. TP (Thanakit Pongpitakmetha) has received speaker honoraria from BL HUA, Daiichi Sankyo, Eisai, Lundbeck, Pfizer, Servier and ZP therapeutics. ST (Sekh Thanprasertsuk) reports speaker and advisory board honoraria from BL HUA, DKSH, Lundbeck, Pfizer, Viatris and ZP therapeutics. TP (Thaninjitra Poonpedpun) declares receiving speaker and advisory board honoraria from DKSH, Lundbeck, Pfizer and ZP therapeutics. PS has received speaker honoraria from BL HUA, DKSH, Pfizer and ZP therapeutics. KS discloses potential interests in receiving speaker honoraria from DKSH, Pfizer and ZP therapeutics. KK has received speaker and advisory board honoraria from BL HUA, DKSH, Lundbeck, Pfizer, Viatris and ZP therapeutics. SK declares receiving honoraria as a speaker for BL HUA, DKSH, Lundbeck, Pfizer, Viatris and ZP therapeutics, as well as participation in advisory board meeting of Lundbeck. Both PD and CT report receiving an advisory board honorarium from Pfizer. NS has received speaker and advisory board honoraria from Abbott, A.Menarini, Bayer, BL HUA, Daiichi Sankyo, DKSH, Lundbeck, Novartis, Orion, Pfizer, Viatris and ZP therapeutics. NY received speaker and advisory board honoraria from BL HUA, Pfizer and ZP therapeutics. ST (Surat Tanprawate) discloses receiving speaker and advisory board honoraria from BL HUA, DKSH, Lundbeck, Pfizer, Viatris and ZP therapeutics.
